Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer
- PMID: 34961307
- DOI: 10.1021/acsami.1c21924
Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer
Abstract
Trastuzumab combined with chemotherapy is the first-line treatment for advanced HER2-positive gastric cancer, but it still suffers from limited therapeutic efficiency and serious side effects, which are usually due to the poor delivery efficiency and the drug resistance of tumor cells to the chemotherapeutic drugs. Herein, a type of ultrasound microbubble for simultaneous delivery of sonosensitizers and therapeutic antibodies to achieve targeting combination of sonodynamic therapy and antibody therapy of HER2-positive gastric cancer was constructed from pyropheophorbide-lipid followed by trastuzumab conjugation (TP MBs). In vitro and in vivo studies showed that TP MBs had good biological safety, and their in vivo delivery can be monitored by ultrasound/fluorescence bimodal imaging. With ultrasound (US) located at the tumor area, TP MBs can be converted into nanoparticles (TP NPs) in situ by US-targeted microbubble destruction; plus the enhanced permeability and retention effects and the targeting effects of trastuzumab, the enrichment of sonosensitizers and antibodies in the tumor tissue can be greatly enhanced (∼2.1 times). When combined with ultrasound, TP MBs can not only increase the uptake of sonosensitizers in HER2-positive gastric cancer NCI-N87 cells but also efficiently generate singlet oxygen to greatly increase the killing effect on cells, obviously inhibiting the tumor growth in HER2-positive gastric cancer NCI-N87 cell models with a tumor inhibition rate up to 79.3%. Overall, TP MBs combined with US provided an efficient way for co-delivery of sonosensitizers and antibodies, greatly enhancing the synergistic therapeutic effect on HER2-positive gastric cancer while effectively reducing the side effects.
Keywords: HER2-positive gastric cancer; microbubbles; sonodynamic therapy; targeted therapy; trastuzumab.
Similar articles
-
The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer.Cancer Lett. 2016 Sep 28;380(1):20-30. doi: 10.1016/j.canlet.2016.06.005. Epub 2016 Jun 15. Cancer Lett. 2016. PMID: 27317872
-
In situ conversion of rose bengal microbubbles into nanoparticles for ultrasound imaging guided sonodynamic therapy with enhanced antitumor efficacy.Biomater Sci. 2020 May 6;8(9):2526-2536. doi: 10.1039/c9bm02046b. Biomater Sci. 2020. PMID: 32215400
-
Ultrasound-mediated delivery of siESE complexed with microbubbles attenuates HER2+/- cell line proliferation and tumor growth in rodent models of breast cancer.Nanotheranostics. 2019 May 13;3(2):212-222. doi: 10.7150/ntno.31827. eCollection 2019. Nanotheranostics. 2019. PMID: 31183315 Free PMC article.
-
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives.Drugs. 2020 Mar;80(4):401-415. doi: 10.1007/s40265-020-01272-5. Drugs. 2020. PMID: 32077003 Review.
-
[Predictive diagnosis of HER2 in gastric adenocarcinoma].Cesk Patol. 2011 Oct;47(4):160-3. Cesk Patol. 2011. PMID: 22145214 Review. Czech.
Cited by
-
Nanoparticles for Augmenting Therapeutic Potential and Alleviating the Effect of Di(2-ethylhexyl) Phthalate on Gastric Cancer.ACS Appl Mater Interfaces. 2024 Apr 17;16(15):18285-18299. doi: 10.1021/acsami.3c15976. Epub 2024 Apr 4. ACS Appl Mater Interfaces. 2024. PMID: 38574184 Free PMC article.
-
Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy.Mater Today Bio. 2023 Dec 22;24:100926. doi: 10.1016/j.mtbio.2023.100926. eCollection 2024 Feb. Mater Today Bio. 2023. PMID: 38179429 Free PMC article. Review.
-
Research progress on reactive oxygen species production mechanisms in tumor sonodynamic therapy.World J Clin Cases. 2023 Aug 6;11(22):5193-5203. doi: 10.12998/wjcc.v11.i22.5193. World J Clin Cases. 2023. PMID: 37621595 Free PMC article. Review.
-
Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy.Pharmaceutics. 2023 May 30;15(6):1625. doi: 10.3390/pharmaceutics15061625. Pharmaceutics. 2023. PMID: 37376072 Free PMC article. Review.
-
Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics.Theranostics. 2023 Apr 23;13(8):2471-2491. doi: 10.7150/thno.82189. eCollection 2023. Theranostics. 2023. PMID: 37215569 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous